Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease.
Heiss JD, Ray-Chaudhury A, Kleiner DE, Ehrlich DJ, Scott G, Edwards NA, Goldstein DS, Hammoud DA, Hadaczek P, Van Laar VS, Graff SA, Herscovitch P, Lungu C, Hallett M, Lonser RR, Zaghloul KA, Bankiewicz KS.
Heiss JD, et al. Among authors: edwards na.
Mov Disord. 2024 Aug;39(8):1412-1417. doi: 10.1002/mds.29820. Epub 2024 May 8.
Mov Disord. 2024.
PMID: 38718138